Remove what-we-do
article thumbnail

With All the Organ Donation Scrutiny, Ask: What Can We Do to Reduce the Need? 

MedCity News

People do not have to die waiting for a kidney. The post With All the Organ Donation Scrutiny, Ask: What Can We Do to Reduce the Need? A VBC approach can lead to earlier identification of kidney disease and better management in its earlier stages. appeared first on MedCity News.

article thumbnail

What Do We Do with All of This Data?

MedCity News

Today, clinicians have to spend an inordinate and impractical amount of time combing through the EHR just to find the information they need to provide that level of care. All of that back-end administrative work should be the function of technology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What do we need to do to accelerate the shift to value-based care?

Clarify Health

Colin Hung from Healthcare IT Today sat down with Keith Florance, SVP, GM Payer Solutions at Clarify Health to discuss what is working to drive value-based transformation and where the industry can focus to accelerate the shift from fee-for-service to value. Watch the interview or read the transcript below to find out what Keith had to say.

article thumbnail

Sustainability - at the heart of what we do

PharmaTech

At Eurofins, we believe that sustainability is at the heart of what we do. Across our network of companies globally and regionally in North America, Eurofins has made a significant amount of progress related to our Environmental, Social and Governance initiatives.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? Learning Objectives: Dose-response curves and patient treatment: How do pharmacologic and toxicologic principles apply to the dosing of drugs in clinical development? A recent draft from the FDA provides valuable insight.

article thumbnail

To Continue the Momentum in Women’s Health, We Have No Time to Lose

MedCity News

We must look both “upstream” – at advocating for change on an institutional level – and “downstream” – at what we can do as individuals to help women secure the care they need. The post To Continue the Momentum in Women’s Health, We Have No Time to Lose appeared first on MedCity News.

111
111
article thumbnail

What to look for when hiring in pharma

World of DTC Marketing

However, some pharma companies are having problems filling open positions, and when they do, they often find it wasn’t a good fit. They should be avoided at all costs if it has to do with money and job title. 2wo: Do you believe? It’s not just that they can do the job. 3hree: What motivates them?

Pharma 281